Login / Signup

Unraveling the Efficacy of Therapeutic Interventions for Short Cervix: Insights from a Retrospective Study for Improved Clinical Management.

Alina-Madalina LucaElena Silvia BernadDragos NemescuConstantin-Cristian VaduvaAnamaria HaraborAna-Maria AdamValeriu HaraborAurel NechitaCristina StrobescuRaluca MogosAlexandru CărăuleanuIngrid Andrada VasilacheDemetra Socolov
Published in: Medicina (Kaunas, Lithuania) (2023)
Background and Objectives : Preterm birth (PTB) is associated with important neonatal mortality and morbidity. The aim of this study was to retrospectively evaluate the average treatment effects on the treated and the efficacity of various therapeutic interventions for PTB in a cohort of patients with singleton pregnancies and short cervical lengths. Materials and Methods : This observational retrospective study included 1146 singleton pregnancies at risk of PTB that were segregated into the following groups: intravaginal progesterone (group 1), Arabin pessary (group 2), McDonald cerclage (group 3), intravaginal progesterone and Arabin pessary (group 4), and intravaginal progesterone and cerclage (group 5). Their treatment effects were evaluated and compared. Results : All evaluated therapeutic interventions significantly reduced the occurrence of late and early preterm births. The risk of late and early PTB was lowered for those pregnant patients who received progesterone and pessaries or progesterone and cerclage in comparison with those who received only progesterone. The extremely PTB risk of occurrence was significantly lowered only by the administration of progesterone in association with cervical cerclage in comparison with progesterone monotherapy. Conclusions : The combined therapeutic interventions had the highest efficacy in preventing preterm birth. An individualized evaluation is needed to establish the best therapeutic approach in particular cases.
Keyphrases
  • preterm birth
  • gestational age
  • low birth weight
  • estrogen receptor
  • physical activity
  • birth weight
  • clinical trial
  • cardiovascular disease
  • coronary artery disease
  • open label
  • study protocol